ACC xenografts treated with the drug combination had lower expressions of β-catenin and vimentin with higher expression of cleaved caspase-3 by IHC as compared to control groups, which validated in vitro findings (Fig. 8G). The gene discussed is VIM; the disease is adrenal cortex carcinoma.